Breathing Performance of Healthy Young Adult

June 9, 2022 updated by: Ching-Hsia Hung, National Cheng-Kung University Hospital

Investigation of Breathing Performance of Healthy Young Adult

The study will recruit subject of healthy adult, COPD-like patient and patient with COPD to investigate the difference of respiratory performance. We will measure the body composition, respiratory muscle force, pulmonary function and performance of voluntary cough. The muscle thickness of abdominal muscle and diaphragm, assessment of diaphragm during different breathing pattern and the muscle activation during voluntary cough will also being determined. We hypothesized that there will be a significantly different between three group on the performance of voluntary cough, and the correlation between each variable will be further investigated.

Study Overview

Status

Completed

Conditions

Detailed Description

The specific aims of the study are:

  1. difference of respiratory muscle performance between three groups
  2. the correlation between respiratory symptom and pulmonary functional test
  3. difference of functional respiratory performance (peak cough flow of voluntary cough) between three groups
  4. muscle activation of abdominal muscle and diaphragm during performing voluntary force
  5. performance of diaphragm under different breathing load

Study Type

Observational

Enrollment (Actual)

65

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tainan, Taiwan, 704
        • National Cheng Kung University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  1. Health subject: healthy adults with no existed respiratory condition
  2. COPD-like subject: subjects with COPD-like symptoms but not reach the diagnosis criteria
  3. COPD subject: subjects with diagnosed COPD

Description

  1. Health subject

    Inclusion Criteria:

    • aged 20 years or above
    • currently not being diagnosis as COPD
    • less than 4 times/week of aerobic exercise
  2. COPD-like subject

    Inclusion Criteria:

    • aged 20 years or above
    • currently not being diagnosis as COPD
    • presented of COPD symptoms (coughing, sputum production and dyspnea), last for 3 months and more than 2 years
    • score more than 1 on modified Medical Research Council (mMRC) or COPD Assessment Test (CAT)
  3. COPD subject

Inclusion Criteria:

  • aged 20 years or above
  • currently being diagnosis as COPD
  • haven't participated in any pulmonary rehabilitation program in the past three months

Exclusion Criteria:

  • Untreated comorbidities for COPD
  • Postural asymmetries (Scoliosis, length discrepancy of the lower limbs or other previous surgical history of spine)
  • Chronic nonspecific lumbopelvic pain
  • Gynecological or abdominal surgery in the previous year
  • Pregnancy or post-delivery in the previous 6 months
  • Neurological or inflammatory disorders
  • Any conditions that may interfere with the data collection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Health adult

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak cough flow
Time Frame: baseline
Peak coughing velocity of voluntary cough in liter/second
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory muscle force
Time Frame: baseline
MIP/MEP in cmH2O
baseline
Pulmonary function test
Time Frame: baseline
PEF/MVV in liter/min
baseline
Pulmonary function test
Time Frame: baseline
FEV1/FVC/VT in liter
baseline
Pulmonary function test
Time Frame: baseline
MVV rate in breaths/min
baseline
Muscle thickness during voluntary force
Time Frame: baseline
tRA/tEO/tIO/tTrA/tD in millimeter
baseline
Muscle activation during voluntary force
Time Frame: baseline
aURA/aLRA/aEO/aIOTrA/aD (all the data will be collected through surface EMG and will be presented as maximal voluntary contraction in %)
baseline
Diaphragm assessment
Time Frame: baseline
QB_ex/DB_ex/Sniff_ex in millimeter
baseline
Diaphragm assessment
Time Frame: baseline
QB_slope/DB_slope/Sniff_slope in cm/s
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ching-Hsia Hung, PhD, Department of Physical Therapy, National Cheng Kung University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2021

Primary Completion (Actual)

May 13, 2021

Study Completion (Actual)

April 20, 2022

Study Registration Dates

First Submitted

April 15, 2021

First Submitted That Met QC Criteria

April 20, 2021

First Posted (Actual)

April 23, 2021

Study Record Updates

Last Update Posted (Actual)

June 10, 2022

Last Update Submitted That Met QC Criteria

June 9, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD

Subscribe